
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO,
This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in
This announcement contains inside information
JPMorgan Japan Small Cap Growth & Income plc ("JPMorgan Japan Small Cap" or "JSGI")
Combination of JFJ and JSGI
Introduction
The boards of JPMorgan Japanese and JPMorgan Japan Small Cap are pleased to announce that the companies have agreed heads of terms for a combination of the two companies. The combination will be undertaken through a scheme of reconstruction by JSGI under s110 of the Insolvency Act 1986 (the "Scheme"), under which JSGI's assets will be rolled into JFJ in exchange for the issue of new JFJ shares to the continuing JSGI shareholders (the "Transaction"). Under the terms of the Scheme, JSGI shareholders will be entitled to realise up to 25 per cent. of their investment in JSGI for cash.
The current investment manager of both companies, JPMorgan Asset Management ("JPMorgan"), and JFJ's lead portfolio managers,
The respective boards and JPMorgan believe that the outlook for Japanese equities remains compelling with a combination of improving economic fundamentals, structural transformation and corporate governance reforms. The new combined entity, JFJ, will represent a very attractive way to invest in this opportunity. The Transaction would result in a company with net assets of up to approximately
Benefits of the Transaction
The combination is expected to result in substantial benefits for both JSGI and JFJ shareholders:
· Broad All-Cap strategy to capture a compelling investment opportunity: The JPMorgan portfolio managers have an unconstrained approach. This means that they can and do invest anywhere in the market cap spectrum, depending on where they see the best opportunities. The investment opportunity in
· Continued access to the market leading resources of JPMorgan: The investment manager of both companies is JPMorgan, an institutional asset manager with
· Increased scale: JFJ is a constituent of the
· Reduced management fees: Subject to the successful completion of the Transaction, the
· Lower ongoing charges: JFJ's expected ongoing charges ratio (OCR), pro forma for the Transaction (and excluding the costs and cost contribution in relation to the Transaction) is expected to be 0.63% in the 12 months following the Transaction. This compares to JFJ's OCR of 0.75% in the half year to
· Active approach to discount management: The JFJ Board takes an active approach to managing the discount and has done so since early 2022. The JFJ Board believes that this approach has dampened share price volatility and moderated the discount. This has contributed to JFJ consistently trading at a narrower discount than its immediate direct peer group. Over the 12 months to
· Direct cost neutrality: JPMF has agreed to cover the direct costs of the Transaction such that there is no NAV dilution for either JFJ or JSGI shareholders receiving new JFJ Shares pursuant to the Transaction from these costs.
· Economic uplift for JSGI Shareholders: JFJ is currently trading at a c.8.8% discount to NAV - its 12-month average is 8.7%. This compares to a current discount of c.13.8% for JSGI, with a 12-month average of 12.5%. JSGI's shareholders are therefore expected to receive an uplift in the value of their holding following completion of the Transaction. In addition, JSGI shareholders may elect for the Cash Option, up to an aggregate limit of 25% of JSGI's outstanding shares, at a 2% discount to the JSGI Residual FAV (as defined below) less the costs of realising the assets required to create the cash pool.
The Transaction
The Transaction will be effected by way of a scheme of reconstruction of JSGI under section 110 of the Insolvency Act 1986, resulting in the voluntary liquidation of JSGI and the transfer of JSGI's assets to JFJ in exchange for the issue of new ordinary shares of JFJ ("New JFJ Shares") to existing JSGI shareholders. The number of New JFJ Shares issued to JSGI shareholders will be determined on a Formula Asset Value ("FAV") for FAV basis.
In accordance with customary practice for such transactions involving investment trusts, the City Code on Takeovers and Mergers is not expected to apply to the Transaction. The Transaction will be subject to, inter alia, the approval of JSGI shareholders and the shareholders of JFJ, in addition to necessary regulatory and tax approvals.
Subject to, and conditional on, the Scheme becoming unconditional and the Transaction completing successfully, qualifying JSGI shareholders will be entitled to elect to receive in respect of some, or all, of their JSGI shares:
(i) New JFJ Shares; and/or
(ii) a cash distribution (the "Cash Option") which, on an aggregate basis will be limited to 25 per cent. of JSGI's shares in issue (excluding treasury shares). Should total elections for the Cash Option exceed 25 per cent. of JSGI's shares in issue (excluding treasury shares), excess elections for the Cash Option will be scaled back on a pro rata basis.
New JFJ Shares will be issued as the default option under the Scheme in the event that JSGI shareholders do not make a valid election under the Scheme or only elect for the Cash Option in respect of a proportion of their shares, or to the extent elections for the Cash Option are scaled back as a result of the Cash Option being oversubscribed.
The Cash Option will be offered at a discount of 2 per cent. to the JSGI Residual FAV (the "Cash Discount") less the costs of realising the assets allocated to the cash pool. The JSGI Residual FAV will be the NAV of JSGI adjusted for the liquidation pool, dividends declared but unpaid (if applicable), portfolio realignment costs and the costs of the Transaction.
JPMF has agreed to cover the direct costs of the Transaction incurred by both JFJ and JSGI in the form of a fee waiver on the enlarged JFJ, subject to the Scheme being implemented (the "JPMorgan Cost Contribution"). The JPMorgan Cost Contribution will be for the benefit of JFJ and those JSGI shareholders receiving New JFJ Shares, offsetting actual direct costs incurred by each company.
The New JFJ Shares will be issued on the basis of the ratio between the JSGI Rollover FAV and the JFJ FAV. The "JSGI Rollover FAV" will be the JSGI Residual FAV adjusted for portfolio realignment costs, the JPMorgan Cost Contribution, and the benefit of the aggregate Cash Discount (capped at the value of the portfolio realignment costs). The JFJ FAV will be the JFJ NAV adjusted for portfolio realignment costs, dividends declared but unpaid (if applicable), direct transaction costs and the JPMorgan Cost Contribution.
Gearing
It is expected that JSGI's existing debt facilities will be repaid and closed prior to the implementation of the Scheme. There will be no change to the gearing policy of JFJ following completion of the Transaction.
New Management Fee Structure
As part of the Transaction, and conditional upon the Transaction being implemented, JPMF has agreed a new management fee structure for JFJ pursuant to which JPMF will be paid an annual fee for its management services, as follows:
- 0.6% up to and including the first
- 0.4% on net assets between
- 0.35% on net assets in excess of
The new management fee structure will apply with effect from
Board Structure
Following completion of the Transaction, it is expected that the Board of the enlarged JFJ will consist of seven directors, with six from the current board of JFJ and one director from the board of JSGI. The JFJ Board is expected to revert to six directors over the medium-term.
Dividends
It is expected that JSGI will declare a pre-liquidation dividend on or around
New JFJ shares will rank pari passu for the expected final JFJ dividend, which is expected to be declared in
Timetable
It is intended that the documentation in connection with the Transaction will be posted to each of JFJ's and JSGI's shareholders in
"The JFJ Board is pleased to have agreed heads of terms for a combination with JSGI which will result in a larger, more liquid investment trust with net assets approaching
"Over recent months, the board of JSGI, together with its advisers, have considered a number of possible alternatives for the Company. Following the conclusion of this process, the board is delighted to propose the combination of JPMorgan Japan Small Cap Growth & Income plc and
For further information please contact:
|
Contact via Company Secretary |
|
+44 (0) 20 7742 4000 |
|
+44 (0) 20 7597 4000
|
|
|
JPMorgan
|
Contact via Company Secretary |
|
+44 (0) 20 7742 4000 |
Cavendish
Lansons (for Press Enquiries)
|
+44 (0) 20 7220 0500
+44 (0) 7947 364 578 |
Simon Crinage
|
+44 (0) 20 7742 4000 |
Notes
JFJ Legal Entity Identifier: 549300JZW3TSSO464R15
JSGI Legal Entity Identifier: 549300 KP3CRHPQ4RF811
Important Information
This announcement contains information that is inside information for the purposes of Article 7 of the
The information in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. The material contained in this announcement is given as at the date of its publication (unless otherwise marked) and is subject to updating, revision and amendment. In particular, any proposals referred to herein are subject to revision and amendment.
The New JFJ Shares have not been, and will not be, registered under the
The value of shares and the income from them is not guaranteed and can fall as well as rise due to stock market and currency movements. When you sell your investment you may get back less than you originally invested. Figures refer to past performance and past performance should not be considered a reliable indicator of future results. Returns may increase or decrease as a result of currency fluctuations.
This announcement may include statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "anticipates", "expects", "intends", "may", "might", "will" or "should" or, in each case, their negative or other variations or similar expressions. All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the JFJ's or JSGI's respective financial positions, strategies, plans, proposed acquisitions and objectives, are forward-looking statements.
Forward-looking statements are subject to risks and uncertainties and, accordingly, JFJ's or JSGI's actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These forward-looking statements speak only as at the date of this announcement and cannot be relied upon as a guide to future performance. Subject to their respective legal and regulatory obligations, each of JFJ, JSGI and JPMorgan expressly disclaims any obligations or undertaking to update or revise any forward-looking statements contained herein to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required to do so by law or any appropriate regulatory authority.
Cavendish
None of JFJ, JSGI, JPMorgan, JPMF, Cavendish or Investec, or any of their respective affiliates, accepts any responsibility or liability whatsoever for, or makes any representation or warranty, express or implied, as to this announcement, including the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to any of them, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of the announcement or its contents or otherwise arising in connection therewith. Each of JFJ, JSGI, JPMorgan, JPMF and Investec, and their respective affiliates, accordingly disclaim all and any liability whether arising in tort, contract or otherwise which they might otherwise have in respect of this announcement or its contents or otherwise arising in connection therewith.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the